AbCellera Biologics Plans To Use Net Proceeds From Offering to Fund Continued Research, Development and Clinical Advancement of Its Internal Pipeline >ABCL

Dow Jones2026/08/13 04:11

By:Dow Jones

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

Strategists Say Market's ‘Wall of Worry' Is Healthy, Not a Warning Sign

BeInCrypto•2026/09/21 03:12

Canadian Dollar seems vulnerable near August 7 low amid sliding oil prices, trade tensions

FXStreet•2026/09/21 03:09

Houthis claim attacks on Saudi capital, thick smoke seen near Riyadh airport

FXStreet•2026/09/21 02:18

Multiple unions threaten strikes at Barrick’s flagship Mali gold mine, documents show

Mining.com•2026/09/20 17:48